GlaxoSmithKline Pharmaceuticals Limited

NSE:GLAXO.NS

2698.35 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q1
Assets:
Current Assets:
Cash & Cash Equivalents -18,568.232860.76-16,053738.8-16,541.197349.4-13,052.3556.9-28,308.7942,861.871-11,890.75,963-11,372.0374,051.892-6,969.51,461.1-10,618.261,048.115-9,689.61,188.8-11,477.911987.766-12,701.163
Short Term Investments 37,136.46417,926.5232,10616,477.533,082.39417,769.326,104.613,00156,617.58826,165.39523,781.46,399.422,744.0747,320.14513,9395,508.421,236.529,570.14519,379.28,500.822,955.82210,490.14525,402.326
Cash and Short Term Investments 18,568.23218,787.2816,05317,216.316,541.19718,118.713,052.313,557.928,308.79429,027.26611,890.712,362.411,372.03711,372.0376,969.56,969.510,618.2610,618.269,689.69,689.611,477.91111,477.91112,701.163
Net Receivables 03,499.13202,110.701,923.801,65602,05203,586.105,130.29605,301.702,238.75701,065.203,635.2560
Inventory 05,339.1205,374.404,599.706,460.905,346.95405,359.905,466.98105,005.304,830.32204,578.904,864.9350
Other Current Assets 0358.6540292.20300.40278040.3360501.9057.2290624.5061.4750796.7083.2470
Total Current Assets 18,568.23227,984.18616,05324,993.616,541.19724,942.613,052.321,953.728,308.79437,080.32311,890.721,810.311,372.03722,026.5436,969.517,90110,618.2617,748.8149,689.616,130.411,477.91120,061.34912,701.163
Non-Current Assets:
Property, Plant & Equipment, Net 03,122.56403,142.503,151.203,232.903,254.47203,323.503,541.24103,752.708,270.867014,163.4013,670.9680
Goodwill 00000-0.00800000000000000000
Intangible Assets 0235.5380288.50340.9080297.30344.9740386.80433.640451.80496.2510742.90655.40
Goodwill and Intangible Assets 0235.5380288.50340.90297.30344.9740386.80433.640451.80496.2510742.90655.40
Long Term Investments 034.1890-16,348.80-17,648.20-12,883.60-26,2470-6,282.40-7,280.0450-5,466.303,704.2880-8,458.60-10,489.5780
Tax Assets 01,634.47901,476.801,335.501,199.401,131.48101,096.301,031.26101,084.601,104.8640363.10622.2150
Other Non-Current Assets -18,568.2322,726.576-16,05319,149.5-16,541.19721,143.8-13,052.316,353.2-28,308.79430,768.32-11,890.710,204.9-11,372.03711,380.968-6,969.59,658.1-10,618.2630.326-9,689.612,254.2-11,477.91114,592.755-12,701.163
Total Non-Current Assets -18,568.2327,753.346-16,0537,708.5-16,541.1978,323.2-13,052.38,199.2-28,308.7949,252.247-11,890.78,729.1-11,372.0379,107.065-6,969.59,480.9-10,618.2613,606.596-9,689.619,065-11,477.91119,051.76-12,701.163
Total Assets 035,737.532032,702.1033,265.8030,152.9046,332.778030,539.4031,133.608027,381.9031,355.41035,195.4039,113.1090
Liabilities & Equity:
Current Liabilities:
Account Payables 06,248.64305,629.904,277.904,696.505,705.48704,925.604,644.703,880.803,575.85103,332.604,058.1480
Short Term Debt 0121.9590139.60120.80143.80124.530148.10143.7670160.70149.7880004.060
Tax Payables 02,985.78903,218.102,96202,988.602,962.03502,706.201,637.22601,694.801,613.76201,489.601,534.3280
Deferred Revenue 075.50508,262.308,302.900043.47407,429.408,366.27606,504.806,346.93300010,330.340
Other Current Liabilities 08,803.3540586.3056208,112.2011,110.79702,320.501700559.1017004,819.20150.6470
Total Current Liabilities 015,249.461014,618.1013,263.6012,952.5016,984.288014,823.6013,324.743011,105.4010,242.57208,151.8014,543.1950
Non-Current Liabilities:
Long Term Debt 064.691074.2034.6088.6076.23501280202.4990279.20268.612043101.770
Deferred Revenue Non-Current 0-0.009000-181.961000-188.857000-155.708000000022.010
Deferred Tax Liabilities Non-Current 0171.357000181.961000188.857000155.70800000003,125.8320
Other Non-Current Liabilities 02,475.63502,614.302,554.802,562.802,642.69702,633.802,615.56902,724.602,638.17703,156.1022.010
Total Non-Current Liabilities 02,711.67402,688.502,589.402,651.402,718.93202,761.802,818.06803,003.802,906.78903,587.103,171.6220
Total Liabilities 017,961.135017,306.6015,853015,603.9019,703.22017,585.4016,142.811014,109.2013,149.361011,738.9017,714.8170
Equity:
Preferred Stock 0000000000000000028.22100000
Common Stock 01,694.0601,694.101,694.101,694.101,694.0601,694.101,694.0601,694.101,694.0601,694.101,694.060
Retained Earnings 08,764.3520008,114.91400017,425.4250005,468.4110008,755.18100011,875.9060
Accumulated Other Comprehensive Income/Loss 17,776.3977,317.98515,395.513,701.417,412.737,449.70714,54912,854.926,629.5587,510.07312,95411,259.914,990.7971,694.0613,272.711,578.618,206.049-28.22123,456.521,762.421,398.292-1,154.16120,573.289
Other Total Stockholders Equity 00000154.07900000006,134.2660007,756.8080008,982.4870
Total Shareholders Equity 17,776.39717,776.39715,395.515,395.517,412.7317,412.814,54914,54926,629.55826,629.55812,95412,95414,990.79714,990.79713,272.713,272.718,206.04918,206.04923,456.523,456.521,398.29221,398.29220,573.289
Total Equity 17,776.39717,776.39715,395.515,395.517,412.7317,412.814,54914,54926,629.55826,629.55812,95412,95414,990.79714,990.79713,272.713,272.718,206.04918,206.04923,456.523,456.521,398.29221,398.29220,573.289
Total Liabilities & Shareholders Equity 17,776.39735,737.53215,395.532,702.117,412.7333,265.814,54930,152.926,629.55846,332.77812,95430,539.414,990.79731,133.60813,272.727,381.918,206.04931,355.4123,456.535,195.421,398.29239,113.10920,573.289